PlainPharmaWatch

CMS Open Payments · Program Year 2024

Biocircuit Technologies Inc

Biocircuit Technologies Inc reported $69,755.19 across General Payments, Research, and Ownership to 112 physicians and teaching hospitals across 112 transactions.

See the rankings → How this is sourced
$69.8K Below-median payer
All-tracks total
112 Below-median volume
Transactions
112 Below-median reach
Recipients
#1271
of 1,925 companies

Biocircuit Technologies Inc reported $69,755.19 across all CMS Open Payments tracks (General + Research + Ownership) to 112 physicians and teaching hospitals in Program Year 2024 - ranking #1271 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $69,755.19, averaging $622.81 per recipient.

Biocircuit Technologies Inc's payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

18/100

Total payments

F

11/100

Transaction volume

F

11/100

Physician reach

F

11/100

Payment type diversity

F

37/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer biocircuit-technologies-inc Biocircuit Technologies Inc

$69.8K · #1271/1,925 · 0.0% industry · PY2024

  • TOT $69.8K
  • RANK #1271
  • SHARE 0.0%
  • TXN 112
  • RCP 112
  • CAT 3
  • GEN $69.8K
  • TOP1 56.1%
  • PY 2024

Volume peers

Nearest volume peer: Coastal Medical Technologies Llc ($69.5K)

Servier Affaires Medicales$70.3KGrifols, S.A.$70.2KBiocircuit Technologies Inc …$69.8KCoastal Medical Technologies…$69.5KNexus CMF, LLC$69.0K
All-tracks payment totals near Biocircuit Technologies Inc (CMS Open Payments PY2024)

Biocircuit Technologies Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Biocircuit Technologies Inc

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Biocircuit Technologies Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

"Consulting Fee" leads the 3-category general-payment breakdown below at $55.6K (79.8% of General Payments, 24 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Biocircuit Technologies Inc's 3-category general-payment breakdown at $55.6K, 79.8% of the reported total.

How Biocircuit Technologies Inc divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$55.6K2. Food and Beverage$8.0K3. Travel and Lodging$6.1K
Payment Type Amount Transactions
Consulting Fee $55.6K 24
Food and Beverage $8.0K 83
Travel and Lodging $6.1K 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $61,741.13 (88.5%) of $69,755.19 in this company's General Payments records across 79 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Biocircuit Technologies Inc

The five named recipients with the highest reported General Payments from this company

Jonathan Isaacs$39.1KLisa Gfrerer$6.8KKyle Eberlin$6.5KSteven Moran$5.0KAlanna Rebecca$4.3K
  1. 1

    Jonathan Isaacs

    $39,148.67 across 16 reported transactions

  2. 2

    Lisa Gfrerer

    $6,817.28 across 4 reported transactions

  3. 3

    Kyle Eberlin

    $6,500.00 across 5 reported transactions

  4. 4

    Steven Moran

    $5,000.00 across 4 reported transactions

  5. 5

    Alanna Rebecca

    $4,275.18 across 7 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Biocircuit Technologies Inc ranks #1271 of 1,925 by total payments (bottom 34% by spend) but is notably more concentrated than that alone would suggest -- #516 of 1,838 by HHI (top 28% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.

00.81.62.43.13364.43389.53414.53439.53464.6Total payments ($M)Concentration (HHI, 0-10,000)
Biocircuit Technologies Inc (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Biocircuit Technologies Inc's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Biocircuit Technologies Inc.

Organ Recovery Systems, Inc.

HHI 3422

American Rheumatology Network, LLC

HHI 3431

Granata Bio Corporation

HHI 3437

Collegium Pharmaceutical, Inc.

HHI 3442

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Biocircuit Technologies Inc.

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Biocircuit Technologies Inc ranks #1271 of 1,925 by all-tracks total payments, led by "Consulting Fee".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Biocircuit Technologies Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.